Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Ir Med J ; 111(4): 737, 2018 04 19.
Artículo en Inglés | MEDLINE | ID: mdl-30488682

RESUMEN

Suprapubic catheter insertion and exchange is a common urological procedure, but it is not without risks and complications. While bowel perforation is a recognised complication at suprapubic catheter insertion, it is not commonly reported at suprapubic catheter exchange. We report our experience of recognition, diagnosis and subsequent successful management of the most important complication related to suprapubic catheters.


Asunto(s)
Enfermedad Iatrogénica , Perforación Intestinal/etiología , Cateterismo Urinario/efectos adversos , Catéteres Urinarios/efectos adversos , Anciano de 80 o más Años , Humanos , Perforación Intestinal/diagnóstico por imagen , Perforación Intestinal/cirugía , Masculino , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
2.
Ir Med J ; 110(5): 564, 2017 May 10.
Artículo en Inglés | MEDLINE | ID: mdl-28737305

RESUMEN

PSA testing is widespread throughout Europe for diagnostic purposes and follow up. We performed a prospective outpatient cohort study of 250 men (2013-2015) in two hospital sites. Included were those men being followed up by urology with PSA blood testing. First appointments and those men in whom non-PSA tests were ordered by urology were excluded. The median age was 67.2yrs (46-88). Eighty-one point two percent of samples had a combination of 21 different serology tests at an added cost of >€18,000. Abnormal serology resulted in 53 referrals. Twenty-six-six percent of correspondence referenced abnormal serology other than PSA. Follow up of non-PSA test results poses a challenge in an outpatient setting with failure to appropriately follow-up on abnormal results, increased costs, and medico-legal implications. There is currently no Irish legislature in place to safeguard hospital physicians. This study quantifies the levels of expenditure, resources and risk associated with ambulant PSA testing.


Asunto(s)
Pruebas Diagnósticas de Rutina/economía , Antígeno Prostático Específico/sangre , Neoplasias de la Próstata/sangre , Neoplasias de la Próstata/diagnóstico , Anciano , Anciano de 80 o más Años , Estudios de Cohortes , Pruebas Diagnósticas de Rutina/métodos , Pruebas Diagnósticas de Rutina/estadística & datos numéricos , Europa (Continente) , Humanos , Masculino , Persona de Mediana Edad , Pacientes Ambulatorios , Estudios Prospectivos
3.
Minerva Urol Nefrol ; 60(3): 185-96, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18787513

RESUMEN

Robotic surgery is being increasingly used for prostatectomy. Its use in renal surgery has been limited by a perception that it does not offer any extra benefit. This article explores the use of robot assistance in renal surgery. Extensive literature search undertaken using Medline and PubMed. The following keywords were used during the search: robot, robotic, kidney, renal, nephrectomy, partial nephrectomy, pyeloplasty. Relevant articles were extracted and data from these articles presented in the review. Comments on relevant aspects of either technique or results are provided. Apart from initial feasibility studies, little has been published on robot assisted laparoscopic nephrectomy (RALN) for diseased kidneys. Most of the cases of RALN has been carried out in live donors for renal transplantation in a few enthusiastic centres. Experience with robot assisted laparoscopic pyeloplasty (RALP) is more mature. Robot assisted laparoscopic partial nephrectomy (RALPN) is continuing to evolve. Robotic NOTES is currently experimental. Robot assistance seems to have a role in reconstructive renal procedures such as pyeloplasty and partial nephrectomy, due mainly to the precise suturing ability.


Asunto(s)
Nefrectomía/métodos , Robótica , Endoscopía/métodos , Diseño de Equipo , Humanos , Pelvis Renal/cirugía , Trasplante de Riñón/métodos , Laparoscopios , Laparoscopía , Robótica/instrumentación , Uréter/cirugía
4.
Prostate ; 47(3): 183-8, 2001 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-11351347

RESUMEN

BACKGROUND: Apoptotic resistance to androgen ablation represents a significant problem in the treatment of prostate cancer. Over expression of antiapoptotic proteins such as Bcl-2 and mutations in p53 contribute to this resistance. The caspase family of proteases are central executioners of the cell death pathway. They are expressed in normal prostate secretory epithelial cells. Altered expression may represent an additional component leading to cell resistance. The aim of this study was to determine by immunohistochemistry caspase 3 expression in benign prostatic hyperplasia and prostate cancers. METHODS: Twenty-two patients with histologically determined prostate cancer and benign prostatic hyperplasia (BPH) were investigated. All specimens were obtained from patients undergoing surgical resection of the prostate. Immunohistochemical analysis was performed on formalin fixed paraffin embedded sections to assess caspase 3 expression. RESULTS: Caspase 3 was expressed in 18/22 (81.1%) samples, with high expression in BPH which demonstrated staining in both basal and secretory epithelial cells. Increasing grades of prostatic cancer showed a significant loss of expression in secretory epithelial layers and little staining in epithelial cells in high-grade prostatic carcinoma. CONCLUSIONS: Altered caspase 3 expression may represent an additional mechanism of apoptotic resistance to androgen ablation. Prostate 47:183-188, 2001.


Asunto(s)
Carcinoma/enzimología , Caspasas/biosíntesis , Hiperplasia Prostática/enzimología , Neoplasias de la Próstata/enzimología , Apoptosis/fisiología , Carcinoma/genética , Caspasa 3 , Regulación Enzimológica de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Humanos , Inmunohistoquímica , Masculino , Hiperplasia Prostática/genética , Neoplasias de la Próstata/genética , Estadísticas no Paramétricas
5.
Kidney Int ; 59(3): 1059-65, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11231361

RESUMEN

BACKGROUND: Ureteral obstruction (UO) is characterized by reduced blood flow and loss of tissue mass in the involved kidney(s). Vasoactive mediators interact to produce an initial hyperemia, followed by a sustained decrease in renal blood flow in the obstructed kidney. Nitric oxide (NO) has been shown to play a central role in the acute hyperemic response to UO. Its role in the reduced perfusion of prolonged UO is less studied. METHODS: Ureteral obstruction was achieved by ligation of the distal left ureter and maintained for 24 hours. Blood flow was studied in untreated animals and after the administration of the NO synthase (NOS) inhibitor N-mono-methyl L-arginine and the NO donor sodium nitroprusside. Tissue was collected for localization and quantitation of NOS. Serum and renal tissue L-arginine levels were measured in control and UO settings. RESULTS: Blood flow in the obstructed kidney diminished to approximately 50% of control values after 24 hours of UO. NOS blockade led to a further decrease in blood flow. Supplementation with exogenous nitrates restored renal blood flow to levels approaching control values. Serum and tissue L-arginine levels did not change with UO. NOS expression was seen to increase with increasing duration of obstruction, with staining most pronounced in the renal tubules. CONCLUSIONS: NO plays a vasodilatory role even in the hypoperfusion of prolonged UO. The administration of exogenous nitrates has a restorative effect on blood flow, suggesting therapeutic potential in UO.


Asunto(s)
Óxido Nítrico/fisiología , Circulación Renal/fisiología , Obstrucción Ureteral/fisiopatología , Animales , Arginina/sangre , Arginina/metabolismo , Inhibidores Enzimáticos/farmacología , Túbulos Renales/enzimología , Masculino , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo II , Óxido Nítrico Sintasa de Tipo III , Nitroprusiato/farmacología , Ratas , Ratas Sprague-Dawley , Circulación Renal/efectos de los fármacos , omega-N-Metilarginina/farmacología
6.
Curr Urol Rep ; 2(4): 292-6, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12084254

RESUMEN

Sexual health has significant impact on quality of life among men with benign prostatic hyperplasia (BPH). The degree of sexual dysfunction matches the severity of lower urinary tract symptoms (LUTS). Treatment of BPH affects not only LUTS, but sexual function as well. Medical, surgical, and minimally invasive therapies differ in their effect on erectile function, ejaculation, and sexual satisfaction. Choice of treatment modality takes into account baseline sexual function and patient expectations. This review outlines the relationship between LUTS and sexual function and how they change with the currently available treatments.


Asunto(s)
Hiperplasia Prostática/complicaciones , Disfunciones Sexuales Fisiológicas/etiología , Enfermedades Urológicas/complicaciones , Humanos , Masculino
7.
Shock ; 14(6): 605-9, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11131909

RESUMEN

Resolving inflammation is a vital step in preventing the persistence of inflammatory disorders. Neutrophils play a major role in tissue damage associated with an inflammatory response. Their death by apoptosis is central to the final resolution of this response. Thiol depletion with diethylmaleate (DEM) or diamide represent important triggers for neutrophil apoptosis. The mechanism by which this process occurs remains unknown. The apoptotic cascade is associated with a number of cellular changes, including caspase activation and mitochondrial permeability. The aims of this study were to determine the role of mitochondrial permeability and the caspase cascade in thiol depletion-induced neutrophil apoptosis. Total cellular glutathione was reduced by DEM and diamide. This reduction was associated with neutrophil apoptosis and an increase in caspase 3 activity. The effects of DEM were blocked by the caspase 3 inhibitor, Z-DEVD-FMK. Mitochondrial permeability that occurred was also increased during this induction of apoptosis. Bongkrekic acid, a mitochondrial membrane stabilizer, inhibited DEM-induced apoptosis. The inhibitors' effects of LPS or GM-CSF on spontaneous neutrophil apoptosis was reversed by DEM, which was mediated by an increase in caspase 3 activity and independent of mitochondrial disruption. Caspase activation is an important step in glutathione depletion-induced apoptosis in resting and inflammatory neutrophils. Regulation of caspase activity may represent a possible target to trigger apoptosis and resolve inflammatory disorders.


Asunto(s)
Apoptosis/fisiología , Caspasas/metabolismo , Glutatión/metabolismo , Neutrófilos/citología , Neutrófilos/metabolismo , Apoptosis/efectos de los fármacos , Caspasa 3 , Inhibidores de Caspasas , Inhibidores de Cisteína Proteinasa/farmacología , Diamida/farmacología , Humanos , Técnicas In Vitro , Inflamación/etiología , Inflamación/metabolismo , Inflamación/patología , Maleatos/farmacología , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Neutrófilos/efectos de los fármacos , Oligopéptidos/farmacología , Permeabilidad
8.
Cancer ; 88(9): 2092-104, 2000 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-10813721

RESUMEN

BACKGROUND: Glutathione (GSH) maintains an optimum cellular redox potential. Chemical depletion, physical efflux from the cell, or intracellular redistribution of this thiol antioxidant is associated with the onset of apoptosis. The aim of this study was to determine the effects of a thiol-depleting agent, diethylmaleate (DEM), on androgen sensitive and insensitive prostate carcinoma cells. METHODS: LNCaP and PC-3 cell lines were induced to undergo apoptosis by DEM and diamide. Apoptosis was quantified by annexin V binding and propidium iodide incorporation using flow cytometry and was confirmed by DNA gel electrophoresis. Intracellular GSH was quantified using a thiol quantitation kit and the generation of reactive oxygen intermediates was measured using dihydrorhodamine 123. Western blot assessed caspase-3, caspase-8, Bcl-2, and Bcl-XL protein expression. Mitochondrial permeability was measured using DiOC6 and stabilized using bongkrekic acid. RESULTS: DEM and diamide induced apoptosis in both androgen sensitive and insensitive cells. Apoptosis was also induced in an LNCaP transfectant cell line overexpressing Bcl-2. Apoptosis was caspase-3 dependent and caspase-8 independent. Bongkrekic acid partially prevented the effects of DEM on mitochondrial permeability but was unable to prevent the induction of apoptosis. Decreased Bcl-2 and Bci-XL protein expression was observed at the time of initial caspase-3 activation. CONCLUSIONS: This study demonstrates that thiol depletion can be used as an effective means of activating caspase-3 in both androgen sensitive and insensitive prostate carcinoma cells. Direct activation of this effector caspase may serve as a useful strategy for inducing apoptosis in prostate carcinoma cells.


Asunto(s)
Apoptosis/efectos de los fármacos , Carcinoma/patología , Glutatión/efectos de los fármacos , Maleatos/farmacología , Neoplasias de la Próstata/patología , Anexina A5/efectos de los fármacos , Antibacterianos/farmacología , Ácido Bongcréquico/farmacología , Caspasa 3 , Caspasa 8 , Caspasa 9 , Caspasas/análisis , Colorantes , ADN de Neoplasias/análisis , Diamida/farmacología , Inhibidores Enzimáticos/metabolismo , Precursores Enzimáticos/análisis , Glutatión/metabolismo , Humanos , Masculino , Mitocondrias/efectos de los fármacos , Oxidación-Reducción , Propidio , Proteínas Proto-Oncogénicas c-bcl-2/análisis , Especies Reactivas de Oxígeno/metabolismo , Receptores Androgénicos/efectos de los fármacos , Reactivos de Sulfhidrilo/farmacología , Células Tumorales Cultivadas , Proteína bcl-X
9.
Prostate ; 40(4): 261-8, 1999 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-10420155

RESUMEN

BACKGROUND: Prostate cancer has displayed an increase in incidence unparalleled by any other tumor in the last two decades, with a steady, more gradual increase in mortality rate. Current curative strategies are focused on the detection and treatment of early-stage (T1-2 N0 M0), clinically significant tumors. METHODS: To this aim, refinement of surgical approaches, with appropriate adjuvant therapies, will ensure more complete cancer control, while minimizing associated morbidity. New delivery systems for radiotherapy, as well as other energy sources, are evolving, while a number of promising pharmacological agents, including angiogenesis inhibitors and drugs which alter signal transduction pathways, are currently under investigation. Early detection is also being facilitated by a more widespread implementation of screening programs. Advances in tumor markers, and imaging and biopsy techniques, will allow more accurate preoperative staging. These, coupled with improvements in prognostic markers, aid the physician and patient alike in deciding on the suitability of treatment options with better estimation of outcome. Perhaps the most exciting developments in prostate cancer will come from knowledge of the molecular mechanisms underlying carcinogenesis. The potential for the development of diagnostic and therapeutic tools is immense. The efficacy of treatment can be studied at a molecular level, and strategies for preventing or slowing the development of malignancy can be formulated. RESULTS AND CONCLUSIONS Application of this knowledge in the form of gene and cellular therapy and in the development of novel systemic agents is beginning to enter the realm of clinical practice, and it may be in this field that means for cure and prevention of prostate cancer will eventually be found.


Asunto(s)
Neoplasias de la Próstata/terapia , Ensayos Clínicos como Asunto , Progresión de la Enfermedad , Terapia Genética , Hormonas/uso terapéutico , Humanos , Masculino , Tamizaje Masivo , Antígeno Prostático Específico/aislamiento & purificación , Prostatectomía , Neoplasias de la Próstata/diagnóstico , Neoplasias de la Próstata/epidemiología , Neoplasias de la Próstata/genética
10.
Eur J Ultrasound ; 9(1): 55-60, 1999 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10099166

RESUMEN

Benign prostatic hyperplasia (BPH) is an extremely common condition and represents a major health issue in terms of patient numbers and treatment cost. Traditionally, the choice of treatment has been between watchful waiting and surgery, however, the side effects of surgery lead to reluctance for treatment in many men, other than those with severe symptoms and complications. In the last 2 decades there has been a rapid expansion in the number of treatments being offered and the number of patients submitting to novel therapies. Medical management has evolved to achieve a central role in the management of BPH. Heat based treatments are also being investigated with considerable interest. Transrectal high intensity focused ultrasound (HIFU) is one such treatment, which allows radiation-free treatment, without the need for intra-urethral manipulation. Imaging can be performed during treatment and treatment results in symptomatic improvement, which is retained with medium-term follow-up. It involves a brief hospital stay and post-operative complications are few. The use of HIFU has also been extended to the treatment of renal, prostatic and bladder tumours and the results in these areas suggest further expansion of its role in urological practice.


Asunto(s)
Hiperplasia Prostática/terapia , Terapia por Ultrasonido/métodos , Estudios de Seguimiento , Hospitalización , Humanos , Neoplasias Renales/terapia , Masculino , Próstata/diagnóstico por imagen , Hiperplasia Prostática/diagnóstico por imagen , Hiperplasia Prostática/tratamiento farmacológico , Hiperplasia Prostática/cirugía , Neoplasias de la Próstata/terapia , Resultado del Tratamiento , Terapia por Ultrasonido/efectos adversos , Terapia por Ultrasonido/economía , Ultrasonografía , Neoplasias de la Vejiga Urinaria/terapia
11.
Curr Opin Urol ; 8(2): 119-24, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17035853

RESUMEN

Recent study has increased the understanding of the physiological processes occurring in obstructive uropathy, in particular the role played by vasoactive mediators and cellular mechanisms. There is an emphasis on developing effective and less invasive means of detection and treatment of ureteric obstruction, although it remains to be determined how the techniques currently being assessed will impact on clinical practice.

12.
Anal Verbal Behav ; 14: 57-83, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-22477120

RESUMEN

The current study aimed to develop a behavior-analytic model of analogical reasoning. In Experiments 1 and 2 subjects (adults and children) were trained and tested for the formation of four, three-member equivalence relations using a delayed matching-to-sample procedure. All subjects (Experiments 1 and 2) were exposed to tests that examined relations between equivalence and non-equivalence relations. For example, on an equivalence-equivalence relation test, the complex sample B1/C1 and the two complex comparisons B3/C3 and B3/C4 were used, and on a nonequivalence-nonequivalence relation test the complex sample B1/C2 was presented with the same two comparisons. All subjects consistently related equivalence relations to equivalence relations and nonequivalence relations to nonequivalence relations (e.g., picked B3/C3 in the presence of B1/C1 and picked B3/C4 in the presence of B1/C2). In Experiment 3, the equivalence responding, the equivalence-equivalence responding, and the nonequivalence-nonequivalence responding was successfully brought under contextual control. Finally, it was shown that the contextual cues could function successfully as comparisons, and the complex samples and comparisons could function successfully as contextual cues and samples, respectively. These data extend the equivalence paradigm and contribute to a behaviour-analytic interpretation of analogical reasoning and complex human functioning, in general.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA